Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-06-27 Purchase | 2025-06-30 09:09 am | Immuneering Corp | IMRX | Schall Thomas J. Director | 9,500 | $3.6619 | $34,788 | 52,885 (Direct) | View |
| 2025-06-17 Purchase | 2025-06-18 09:11 am | Immuneering Corp | IMRX | Schall Thomas J. Director | 40,485 | $2.2052 | $89,278 | 43,385 (Direct) | View |
| 2024-03-22 Purchase | 2024-03-25 4:03 pm | Immuneering Corp | IMRX | Schall Thomas J. Director | 2,900 | $2.5465 | $7,385 | 2,900 (Direct) | View |
| 2022-10-20 Sale | 2022-10-24 7:01 pm | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 2,393,352 | $0 | $0 | 0 (Direct) | View |
| 2022-08-04 Sale | 2022-08-08 7:41 pm | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 130,000 | $50.24 | $6,531,733 | 2,428,352 (Direct) | View |
| 2020-12-14 Sale | 2020-12-16 7:51 pm | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 28,772 | $65.02 | $1,870,696 | 2,300,152 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-13 Option Award | 2025-06-16 09:15 am | N/A 2035-06-13 | Immuneering Corp | IMRX | Schall Thomas J. Director | 33,350 | $0 | 33,350 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-13 4:26 pm | N/A 2034-06-12 | Immuneering Corp | IMRX | Schall Thomas J. Director | 8,588 | $0 | 8,588 (Direct) | View |
| 2024-03-11 Option Award | 2024-03-12 5:02 pm | N/A 2034-03-11 | Immuneering Corp | IMRX | Schall Thomas J. Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2022-08-04 Exercise | 2022-08-08 7:41 pm | N/A 2023-07-23 | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 130,000 | $0 | 2,428,352 (Direct) | View |
| 2022-08-04 Exercise | 2022-08-08 7:41 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 130,000 | $14.28 | 2,428,352 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-25 8:39 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 345,300 | $0 | 345,300 (Direct) | View |
| 2022-01-01 Exercise | 2022-01-04 9:42 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 84,234 | $0 | 2,480,586 (Direct) | View |
| 2022-01-01 Tax Withholding | 2022-01-04 9:42 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 45,698 | $36.41 | 2,480,586 (Direct) | View |
| 2021-12-01 Exercise | 2021-12-03 7:39 pm | N/A 2022-02-27 | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 45,936 | $0 | 2,354,816 (Direct) | View |
| 2021-12-01 Exercise | 2021-12-03 7:39 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 38,948 | $10.27 | 2,354,816 (Direct) | View |
| 2021-12-01 Exercise | 2021-12-03 7:39 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 6,988 | $14.31 | 2,354,816 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 9:17 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 133,600 | $0 | 133,600 (Direct) | View |
| 2021-01-01 Tax Withholding | 2021-01-07 8:40 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 47,576 | $61.92 | 2,401,348 (Direct) | View |
| 2021-01-01 Exercise | 2021-01-07 8:40 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 87,899 | $0 | 2,401,348 (Direct) | View |
| 2020-12-14 Exercise | 2020-12-16 7:51 pm | N/A 2022-07-24 | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 28,772 | $0 | 2,300,152 (Direct) | View |
| 2020-12-14 Exercise | 2020-12-16 7:51 pm | N/A N/A | ChemoCentryx Inc. | CCXI | Schall Thomas J. President and CEO | 28,772 | $14.31 | 2,300,152 (Direct) | View |